Operating Income for Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's current operating income (TTM) is $15.44B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PFE
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$15.44B
YoY change
-6.3%
5Y CAGR
+11.2%
Peak year (2022)
$37.55B
Cumulative operating income
$419.00B
Operating Income history chart for Pfizer (PFE) from 1985 to 2025
Operating Income history table for Pfizer (PFE) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $15.44B | -6.3% | ||
| 2024 | $16.48B | +211.5% | ||
| 2023 | $5.29B | -85.9% | ||
| 2022 | $37.55B | +80.6% | ||
| 2021 | $20.79B | +128.9% | ||
| 2020 | $9.09B | +21.0% | ||
| 2019 | $7.51B | -50.9% | ||
| 2018 | $15.29B | +6.2% | ||
| 2017 | $14.39B | +0.8% | ||
| 2016 | $14.27B | +7.4% | ||
| 2015 | $13.30B | -5.2% | ||
| 2014 | $14.03B | -16.9% | ||
| 2013 | $16.89B | -6.4% | ||
| 2012 | $18.04B | -1.9% | ||
| 2011 | $18.38B | +3.7% | ||
| 2010 | $17.73B | +10.8% | ||
| 2009 | $16.01B | -3.7% | ||
| 2008 | $16.63B | +19.4% | ||
| 2007 | $13.92B | -7.8% | ||
| 2006 | $15.09B | +3.9% | ||
| 2005 | $14.53B | -15.0% | ||
| 2004 | $17.09B | +58.2% | ||
| 2003 | $10.80B | -12.0% | ||
| 2002 | $12.28B | +11.9% | ||
| 2001 | $10.98B | +26.6% | ||
| 2000 | $8.67B | +90.6% | ||
| 1999 | $4.55B | +26.3% | ||
| 1998 | $3.60B | +7.7% | ||
| 1997 | $3.35B | +8.6% | ||
| 1996 | $3.08B | +20.3% | ||
| 1995 | $2.56B | +29.8% | ||
| 1994 | $1.97B | +116.0% | ||
| 1993 | $913.30M | -36.7% | ||
| 1992 | $1.44B | +15.1% | ||
| 1991 | $1.25B | +19.0% | ||
| 1990 | $1.05B | +8.8% | ||
| 1989 | $968.20M | -4.3% | ||
| 1988 | $1.01B | +7.6% | ||
| 1987 | $940.80M | -2.0% | ||
| 1986 | $959.70M | +9.1% | ||
| 1985 | $880.00M | — |
Operating Income values are taken from Pfizer's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual operating income for Pfizer (PFE) came in at $15.44B – declined 6.3% year-over-year.
Over 2020–2025 (5 years), Pfizer operating income expanded at a +11.2% compound annual rate, with the latest reading among the more recent periods of the dataset.
Pfizer operating income peaked at $37.55B in 2022; the latest annual figure is $15.44B in 2025 (58.9% below peak).
2022 marks the peak operating income at $37.55B, with the historical low of $880.00M recorded in 1985.
Among 8 Healthcare peers, Pfizer (PFE) ranks 7th; the peer median for operating income is $22.84B.
Pfizer Operating Income by Year
Pfizer Operating Income 2025: $15.44B
Pfizer operating income in 2025 was $15.44B, declined 6.3% below 2024.
Pfizer Operating Income 2024: $16.48B
Pfizer operating income in 2024 was $16.48B, surged 211.5% from 2023.
Pfizer Operating Income 2023: $5.29B
Pfizer operating income in 2023 was $5.29B, plunged 85.9% below 2022.
Pfizer Operating Income 2022: $37.55B
Pfizer operating income in 2022 was $37.55B, surged 80.6% from 2021. This figure represents the highest annual value in the available history.
Pfizer Operating Income 2021: $20.79B
Pfizer operating income in 2021 was $20.79B.
See more financial history for Pfizer (PFE).
Sector peers — Operating Income
Companies in the same sector as Pfizer, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Pfizer's operating income?
- Latest reported operating income for Pfizer (PFE) is $15.44B (period ending December 31, 2025).
How has Pfizer operating income changed year-over-year?
- Pfizer (PFE) operating income changed -6.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Pfizer operating income?
- Pfizer (PFE) operating income compound annual growth rate is +11.2% over the most recent 5 years available.
When did Pfizer operating income hit its highest annual value?
- Pfizer operating income reached its highest annual value of $37.55B in 2022.
What was Pfizer operating income in 2024?
- Pfizer (PFE) operating income in 2024 was $16.48B.
What was Pfizer operating income in 2025?
- Pfizer (PFE) operating income in 2025 was $15.44B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PFE Overview
Company profile, financial tools, and key metrics
PFE Revenue Counter
Earns $1,984 every second. See per minute, hour, and day.
PFE Earnings Counter
Earns $246.39 per second net profit. See per minute, hour, and day.
PFE Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
PFE What If Invested
What if you had invested $1,000? See historical returns from any date.
PFE How It Makes Money
Discover visual breakdown of $62.58B in revenue — where it comes from and where it goes.
PFE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PFE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PFE Daily Price Character
Steady · 46.3% historical win rate (green days). Streaks & record days.
PFE Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
PFE Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
PFE Dividend Profile
Yield: 6.55%. Safety: 3/8. See full history.
PFE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
PFE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.